Although India 'has carved out a significant portion of the world
pharma pie', an enormous change in mindset is needed if the country
is to become a global pharmaceutical hub, according to a new report
Having inked two new deals with large Indian contract research
organisations (CROs), US generics major Taro Pharmaceutical
Industries is beginning to shift some of its product R&D to
India in a bid to enhance its competitive position...